Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

By L. Bubendorf, Alain Schöpfer, U. Wagner, G. Sauter, H. Moch, N. Willi, Th. Gasser, M. Mihatsch. Human Pathology, 2000

1,898 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Molecular genetics of prostate cancer: new prospects for old challenges. (2010, background): “As noted above, although common sites of secondary metastasis for prostate cancer are lung, liver, and pleura, if prostate cancer metastasizes, it invariably goes to bone, where it forms characteristic osteoblastic lesions (Bubendorf et al. 2000; Logothetis and Lin 2005).”
Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases (2004, result): “Our data and those of others demonstrate that prostate cancer commonly metastasizes to lymph nodes, liver, lung, adrenal, and dura sites in addition to the bone (20, 24).”
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. (2003, background): “1 on tumorserved bone metastasis and subsequent osteoblastic/osteoinitiation has been reported (Kim et al., 2002).clastic lesions (Bubendorf et al., 2000; Cher, 2001; Harada et PSCA is another molecule that we identified by microarrayal., 1992; Mundy, 2002).”